218 related articles for article (PubMed ID: 24497297)
21. Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?
Grimm M; Shokri B; Alexander D; Munz A; Hoffmann J; Reinert S
Target Oncol; 2013 Sep; 8(3):189-201. PubMed ID: 23314953
[TBL] [Abstract][Full Text] [Related]
22. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.
Curtis KM; Aenlle KK; Roos BA; Howard GA
Mol Endocrinol; 2014 May; 28(5):644-58. PubMed ID: 24597546
[TBL] [Abstract][Full Text] [Related]
23. 1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells.
Lechner D; Kállay E; Cross HS
Mol Cell Endocrinol; 2007 Jan; 263(1-2):55-64. PubMed ID: 17029768
[TBL] [Abstract][Full Text] [Related]
24. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of endoplasmic reticulum stress and oxidative stress by vitamin D in endothelial cells.
Haas MJ; Jafri M; Wehmeier KR; Onstead-Haas LM; Mooradian AD
Free Radic Biol Med; 2016 Oct; 99():1-10. PubMed ID: 27458123
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.
Jolliffe DA; Stefanidis C; Wang Z; Kermani NZ; Dimitrov V; White JH; McDonough JE; Janssens W; Pfeffer P; Griffiths CJ; Bush A; Guo Y; Christenson S; Adcock IM; Chung KF; Thummel KE; Martineau AR
Am J Respir Crit Care Med; 2020 Aug; 202(3):371-382. PubMed ID: 32186892
[No Abstract] [Full Text] [Related]
27. Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)
Olszewska AM; Nowak JI; Myszczynski K; Słominski A; Żmijewski MA
Mol Cell Endocrinol; 2024 Mar; 582():112124. PubMed ID: 38123121
[TBL] [Abstract][Full Text] [Related]
28. Gene expression of vitamin D metabolic enzymes at baseline and in response to vitamin D treatment in thyroid cancer cell lines.
Bennett RG; Wakeley SE; Hamel FG; High RR; Korch C; Goldner WS
Oncology; 2012; 83(5):264-72. PubMed ID: 22992568
[TBL] [Abstract][Full Text] [Related]
29. Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.
Zhang Q; Kanterewicz B; Shoemaker S; Hu Q; Liu S; Atwood K; Hershberger P
J Steroid Biochem Mol Biol; 2013 Jul; 136():264-70. PubMed ID: 23026510
[TBL] [Abstract][Full Text] [Related]
30. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
31. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation.
Lin R; Nagai Y; Sladek R; Bastien Y; Ho J; Petrecca K; Sotiropoulou G; Diamandis EP; Hudson TJ; White JH
Mol Endocrinol; 2002 Jun; 16(6):1243-56. PubMed ID: 12040012
[TBL] [Abstract][Full Text] [Related]
32. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
33. Reprint of "Vitamin D deficiency in pregnant women impairs regulatory T cell function".
Vijayendra Chary A; Hemalatha R; Seshacharyulu M; Vasudeva Murali M; Jayaprakash D; Dinesh Kumar B
J Steroid Biochem Mol Biol; 2015 Apr; 148():194-201. PubMed ID: 25644204
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3.
Kurahashi I; Matsunuma A; Kawane T; Abe M; Horiuchi N
Endocrine; 2002 Mar; 17(2):109-18. PubMed ID: 12041912
[TBL] [Abstract][Full Text] [Related]
36. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
37. Pro-inflammatory signaling by 24,25-dihydroxyvitamin D3 in HepG2 cells.
Wehmeier K; Onstead-Haas LM; Wong NC; Mooradian AD; Haas MJ
J Mol Endocrinol; 2016 Aug; 57(2):87-96. PubMed ID: 27234962
[TBL] [Abstract][Full Text] [Related]
38. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
39. 1α,25-Dihydroxyvitamin D3 Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells.
Ryan ZC; Craig TA; Folmes CD; Wang X; Lanza IR; Schaible NS; Salisbury JL; Nair KS; Terzic A; Sieck GC; Kumar R
J Biol Chem; 2016 Jan; 291(3):1514-28. PubMed ID: 26601949
[TBL] [Abstract][Full Text] [Related]
40. Autocrine metabolism of vitamin D in normal and malignant breast tissue.
Townsend K; Banwell CM; Guy M; Colston KW; Mansi JL; Stewart PM; Campbell MJ; Hewison M
Clin Cancer Res; 2005 May; 11(9):3579-86. PubMed ID: 15867263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
